NDC Code(s) : 0019-9601-10, 0019-9602-20
Packager : Mallinckrodt Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
SODIUM IODIDE I 123sodium iodide i 123 CAPSULE, GELATIN COATED | ||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
SODIUM IODIDE I 123sodium iodide i 123 CAPSULE, GELATIN COATED | ||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
SODIUM IODIDE I 123 CAPSULES
DIAGNOSTIC
For Oral Administration Only
Store at Controlled Room Temperature
20-25°C (68-77°F)
READ PACKAGE INSERT FOR DIRECTIONS FOR USE
Rx Only.
WARNING: Radioactive drugs must be handled only by qualified personnel in conformity with regulations of the U.S. Nuclear Regulatory Commission or state regulatory agencies where applicable. Bottle containing drug should be kept in this container or within a heavier shield.
In Canada:
Mallinckrodt Canada Inc.
Pointe-Claire, Qc
Est. Lic. No. 100107-A
Mallinckrodt Inc.
St. Louis, MO 63134 USA
MALLINCKRODT
CAUTION RADIOACTIVE MATERIAL
A601C0
R9/2000

PRINCIPAL DISPLAY PANEL
SODIUM IODIDE I 123 CAPSULES
DIAGNOSTIC
For Oral Administration Only
Store at Controlled Room Temperature
20-25°C (68-77°F)
READ PACKAGE INSERT FOR DIRECTIONS FOR USE
Rx Only.
WARNING: Radioactive drugs must be handled only by qualified personnel in conformity with regulations of the U.S. Nuclear Regulatory Commission or state regulatory agencies where applicable. Bottle containing drug should be kept in this container or within a heavier shield.
In Canada:
Mallinckrodt Canada Inc.
Pointe-Claire, Qc
Est. Lic. No. 100107-A
Mallinckrodt Inc.
St. Louis, MO 63134 USA
MALLINCKRODT
CAUTION RADIOACTIVE MATERIAL
A602C0
R9/2000
